Comparative pharmacoeconomic assessment of apixaban vs. standard of care for the prevention of stroke in Italian atrial fibrillation patients by Lorenzo Pradelli, Mario Calandriello, Roberto Di Virgilio, Marco Bellone, Marco Tubaro

Get full text

A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data by A. S. Kolbin, L. S. Namazova-Baranova, E. A. Vishneva, M. Y. Frolov, T. L. Galankin, A. A. Alekseeva, E. A. Dobrynina

Subjects: “…pharmacoeconomics…”
Get full text

Impact of Sugammadex Versus Neostigmine/Glycopyrrolate on Perioperative Efficiency by Deyhim N, Beck A, Balk J, Liebl MG

Subjects: Get full text

Pattern of Antidepressant Utilization and Cost in Iran from 2006 to 2013 in Comparison with Other Countries by Fatemeh Soleymani, Forouzan Taheri, Elizabeth Roughead, Shekoufeh Nikfar, Mohammad Abdollahi

Subjects: Get full text

Las reacciones adversas a medicamentos: una aproximación desde el punto de vista económico. by Omar Segura, Carlos Maldonado

Subjects: Get full text

Evaluating the validity of the National List of Essential Medicines 2015 for “anesthetic agents” in 2022: An observational cost analysis by H Shafeeq Ahmed

Subjects: Get full text

Cost-Effectiveness Analysis of Antihypertensive Therapy in Outpatient Hypertension Patients at Hospital X in Wajo Regency by Ida Adhayanti, Alya Rahmah Safitri, Ismail Ibrahim

Subjects: Get full text

Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review by Vadim D. Zakiev, Yulia V. Kotovskaya, Olga N. Tkacheva

Subjects: Get full text

Economic benefit of using testosterone gel (used externally) in men with diabetes mellitus and testosterone deficiency by Alexandr A. Astapovskiy, Alina A. Bagdasaryan, Konstantin I. Aref’ev, Svetlana Y. Serebrova, Evgeniya V. Shikh, Vladimir N. Drozdov

Subjects: Get full text

Pharmacoeconomic analysis of Flemoclav Solutab® use in adult patients with acute sinusitis in routine outpatient clinical practice in Russia by A. S. Kolbin, I. A. Vilum, M. A. Proskurin, Yu. E. Balykina

Subjects: Get full text

Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs by Y. I. Ashikhmin, D. Yu. Belousov

Subjects: Get full text

PHARMACOECONOMIC EVALUATION OF RIBOCICLIB FOR THE FIRST-LINE TREATMENT OF HR-POSITIVE HER2-NEGATIVE ADVANCED BREAST CANCER by N. A. Avksentyev, M. V. Zhuravleva, E. M. Pazukhina, A. V. Snegovoy, M. Yu. Frolov

Subjects: Get full text

Pharmacoeconomic study of rivaroxaban and acetylsalicylic acid combination use in patients with coronary artery disease and/or peripheral artery disease by N. V. Pogosova, A. V. Panov, A. Yu. Kulikov, V. G. Serpik, V. A. Kulikov

Get full text

Pharmacoeconomic analysis of the choice of antimicrobial drugs for the treatment of community-acquired pneumonia by physicians and final year medical students by V. G. Deriushkin, S. V. Gatsura

“…The authors of the article conduct a pharmacoeconomic analysis of antimicrobial agents (AMA) prescriptions based on a survey of graduates of the medical faculty of a medical university and outpatient healthcare practitioners in Moscow. …”
Get full text

Regional features of management of patients diagnosed with chronic gastritis at the inpatient and outpatient-polyclinic stages. Brief pharmacoeconomic analysis by E. N. Chicherina, M. A. Matasova, A. S. Knyazeva

Get full text

The pharmacoeconomic comparison of the fixed insulin glargine and lixisenatide combination with insulin degludec family in type 2 diabetes mellitus by I. N. Dyakov, S. K. Zyryanov

Get full text

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia by V. G. Deriushkin, A. P. Ternavskii, S. V. Gatsura

Subjects: Get full text

Pharmacoeconomic analysis of using empegfilgrastim for the treatment of early and locally advanced HER2+ breast cancer in the Russian Federation by M. V. Zhuravleva, K. A. Kokushkin, E. A. Luchinin, E. V. Luchinina, T. R. Kameneva, E. V. Kuznetsova, V. S. Krysanova, E. V. Makarova, L. G. Zhukova

“…We searched and analyzed published clinical, epidemiological and pharmacoeconomic studies as well as regulatory and legal documents. …”
Get full text

PHARMACOECONOMIC STUDY OF LENVIMA (LENVATINIB) IN ADVANCED PROGRESSIVE RADIO IODINE REFRACTORY DIFFERENTIATED THYROID CANCER IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

Subjects: Get full text

Use of Machine Perfusion to Increase the Number of Expanded Criteria Deceased Donor Kidney Transplants: A Pharmacoeconomic Analysis by Helio Tedesco Silva, Jr, MD, PhD, Teresa Raquel de Moraes Ramos, PhD, Deise De Boni Monteiro de Carvalho, MD, Gustavo Fernandes Ferreira, MD, PhD, João Marcelo Medeiros de Andrade, MD, PhD, Luis Gustavo Modelli de Andrade, MD, PhD, Mario Abbud-Filho, MD, PhD, Renato Demarchi Foresto, MD, MSc, Roberto Ceratti Manfro, MD, PhD, Ronaldo de Matos Esmeraldo, MD, MSc, Tainá Veras de Sandes Freitas, MD, PhD, Valter Duro Garcia, MD, PhD, José Medina Pestana, MD, PhD, Marcelo Cunio Machado Fonseca, MD, PhD

“…Real-life data were used to compose the cohort characteristics in this model. This pharmacoeconomic analysis aimed to determine the cost-effectiveness and budgetary impact of using machine perfusion to preserve ECD kidneys. …”
Get full text